Recently, in 2020, the development of PLGDA-based NPs containing SAHA and catalase (a biological peroxidase), using a double emulsion method, allowed to overcome the radiation resistance due to tumor microenvironments, including hypoxia and histone deacetylase (HDAC) overexpression [69]. This evidence concerns the gene HDAC9 and neoplasm.